“…Amongst all antioxidants, ascorbate appears to be the most attractive option for treating and preventing IRI in the lung [20,21] and other organs [24][25][26][27][28][29]. Ascorbate administration has been shown to reduce oxidative damage in endothelial cells [30,31], improve tissue perfusion [32], inhibit tumor necrosis factor α (TNFα) [33], reduce mitochondrial swelling and damage [27], preserve mitochondrial respiration [34], reduce edema [35], reduce proinflammatory chemokine expression [36], and reduce oxidative damage [37,38].…”